Celon Pharma Dividend
What is Celon Pharma current dividend yield, its reliability and sustainability?
[object Object] Score0/6
Dividend Score 0/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Celon Pharma Dividend Yield vs Market|
|Market Bottom 25% (PL)||2.8%|
|Market Top 25% (PL)||8.4%|
|Industry Average (Pharmaceuticals)||2.6%|
|Analyst forecast in 3 Years (CLN)||0.7%|
Notable Dividend: CLN's dividend (1.93%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.72%).
High Dividend: CLN's dividend (1.93%) is low compared to the top 25% of dividend payers in the Polish market (8.44%).
Stability and Growth of Payments
|Month||Dividend Per Share (annual)||Avg. Yield (%)|
Stable Dividend: CLN has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: CLN's dividend payments have increased, but the company has only paid a dividend for 6 years.
Earnings Payout to Shareholders
Earnings Coverage: CLN is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: CLN is paying a dividend but the company has no free cash flows.